Antihypertensives and risk of hypoglycemia in elderly hypertensive diabetic patients using antidiabetic drugs

Wenlu Tang,Yongming Wang,Wenmin Du,Nengneng Cheng,Binyan Chen

DOI: https://doi.org/10.3969/j.issn.1007-4406.2005.04.005

2005-01-01

Abstract:AIM To determine the relationship between antihypertensives and the risk of hypoglycemia in elderly hypertensive diabetic patients using antidiabetics. METHODS We conducted a population-based, retrospective cohort study of 1 324 hypertensive patients with elderly diabetes mellitus (DM) who were selected from a database of the monitoring system for antidiabetic drugs in elderly diabetic population from five administrative areas in Shanghai and used the antidiabetics between 2001 June and 2002 June. The observational end point was hypoglycemia definitely diagnosed in hospitals. Descriptive statistical methods and Poisson regression model including multi-covariables were also used to identify the rates and the adjusted relative risk (RR) of hypoglycemia relating to antihypertensives. RESULTS We identified 34 persons with a first episode of hypoglycemia during the study period. The crude rate of hypoglycemia among antihypertensives users (2.76 % ) was higher than that in nonusers of antihypertensives (1.51% ). While the increase had no satistically significant after controlling the confounding factors. With adjustment for a wide range of potential confounding factors, hypoglycaemia was significantly associated with current use of compound antihypertensive tablets and other antihypertensives in combination medications among the elderly hypertensive diabetic patients using sulphonylureas compared with antihypertensive nonusers (RR, 6.87; 95% confidence interral(CI), 1.01 -47.21). Using the above group as the refevence, other classes of antihypertensive including cardioselective β-Blockers, diuretics, Zhenju antihypertensive tablets, calcium channel blockers (CCBs), angiotensin-converting enzyme (ACE) inhibitors had no higher risks of hypoglycemia( P ＞ 0.05), while among them ACE inhibitors in single medication would be cautious because of its highest incidence of hypoglycemia(4.91 % ). CONCLUSION Some traditional compound preparations like compound antihypertensive tablets could increase the risk of hypoglycemia among elderly hypertensive diabetic patients using sulphonylureas. Selection of antihypertensive agents should be judicious, based on not only the effectiveness but also the impact on metabolic control for elderly diabetic patients.